Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.

Histopathology - 1 Mar 2013

Matsubara Akiko, Sekine Shigeki, Yoshida Masayuki, Yoshida Akihiko, Taniguchi Hirokazu, Kushima Ryoji, Tsuda Hitoshi, Kanai Yae

Abstract excerpt

AIMS: To determine the prevalence of MED12 mutations in smooth muscle tumours of different organs. METHODS AND RESULTS: A total of 142 smooth muscle tumours of the uterus, gastrointestinal tract, retroperitoneum and soft tissue were analysed for MED12 mutations using Sanger sequencing. Among the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Mutational Analysis
Share to Gastrointestinal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leiomyoma

Share to Mediator Complex

Share to Mutation

Share to Soft Tissue Neoplasms

Share to Uterine Neoplasms

Source

Identifiers

PMID: 23347103
DOI: 10.1111/his.12039

Genes

MED12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23347103-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.PMID 23347103Read ↗

MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.Semantic proximity Read ↗

MED12 alterations in both human benign and malignant uterine soft tissue tumors.Semantic proximity Read ↗

MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.Semantic proximity Read ↗

MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.Semantic proximity Read ↗

Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.Semantic proximity Read ↗

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.Semantic proximity Read ↗

Analysis of MED12 Mutation in Multiple Uterine Leiomyomas in South Korean patients.Semantic proximity Read ↗

MED12 is frequently mutated in ovarian and other adnexal leiomyomas.Semantic proximity Read ↗

Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.Semantic proximity Read ↗

MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.Semantic proximity Read ↗

MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.Semantic proximity Read ↗

Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.